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Abstract
Electrophysical agents (EPAs), including electrotherapy, are important components of patient/client management. A
recent study by Springer et al. has elucidated the pattern of use and factors in clinical decision-making by Israeli
physiotherapists regarding EPAs. It is evident from their data that EPAs, especially those related to electrotherapy,
are still considered relevant to physiotherapy practice. Included in this commentary are observations on the
findings of the current study, as well as recommendations on an alternative approach to the investigation of clinical
decision-making and usage of EPAs. Discussion also includes a proposed and apparent de-emphasis of EPAs in
physiotherapy education and practice in the USA, which may impact some of the factors found in the current
study to be relevant in clinical decision-making and usage for EPAs.
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Commentary
Background and observations on the current study
The current study by Springer et al. [1] has investigated
the contribution of various factors to clinical decision-
making regarding the application of electrophysical
agents (EPAs). My area of experience within EPAs is
primarily in electrotherapy, and my commentary will be
focused in this area. According to the results of the
current study, the greatest availability and frequency of
use of EPAs, apart from heat packs and ultrasound, was
primarily in the electrotherapeutic EPAs.
This study demonstrates that EPAs are considered
relevant to physiotherapy practice and used regularly by
physiotherapists in Israel, although only heat packs,
interferential current (IFC), and transcutaneous elec-
trical nerve stimulation (TENS) are used daily by as
many as approximately 50 % of the study’s participants.
The lesser usage of some EPAs may be related to avail-
ability, although cold packs and ice had high availability
but relatively low usage. Of the electrotherapeutic EPAs,
the least used was functional electrical stimulation
(FES). These may be due to the fact that the greatest
number of physiotherapists participating in the study
were practicing in the area of orthopedic and sports
rehabilitation (62.5 %), in which there is typically not
much indication for FES; as opposed to neurologic re-
habilitation (20.1 %), the area in which FES is more often
used.
The factors with the greatest frequencies of “strong” or
“very strong” influence on the use of EPAs appeared to
be previous clinical experience, availability of equipment,
and degree of self-confidence operating the device, with
frequencies between approximately 60–80 %. It would
seem that greater availability would lead to more clinical
experience, which in turn would lead to greater self-
confidence. The factors with next highest levels of influ-
ence, with frequencies between 50 and 60 %, were entry-
level and continuing education, as well as research evi-
dence for efficacy. I would consider it to be a more de-
sirable outcome for these factors to be much higher. I
am unfamiliar with education and practice in Israel
where this study and its participants are based. However,
there are potential factors and issues in the United States
that would explain results that would be disappointing
in these areas, which will be discussed later in the com-
mentary. This study also found that the preferences of
the patient do not seem to play a major role in clinical
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decision-making regarding EPAs. This seems disappoint-
ing given the importance placed on it within the frame-
work of evidence-based practice. However, it may be
that clinicians do not believe that most patients are well-
informed regarding EPAs compared to the clinicians
themselves, enough to make an appropriate decision on
incorporating EPAs into their own treatment program.
This also may not be very different from the influence of
patient preference on other intervention choices. Per-
haps this can be addressed through patient education on
EPAs, by physiotherapists.
The current study has investigated numerous EPAs.
This is a large endeavor that covers a lot of ground, but
it may sacrifice some of the details that can help clarify
specific issues related to patterns of use of smaller or
individual categories (as they were defined in the study)
of EPAs. This might prevent results that could be
misleading in the low or high extremes.
Issues in the investigation of clinical decision-making
and usage
The current study has investigated electrotherapy with
respect to device classifications, i.e., FES, neuromuscular
electrical stimulation (NMES), TENS, and IFC, rather
than interventions or treatment purposes. This is appro-
priate if one is interested in the use of types of devices.
The first three have come to be synonymous with par-
ticular treatment purposes. FES is associated with the
use of electrotherapy for orthotic substitution for func-
tion, such as stimulating dorsiflexion during the swing
phase of gait. NMES has come to be associated with
treatment purposes for enhancing muscle performance
such as strengthening, while TENS is a term that has
long been considered synonymous with pain control.
However, these classifications or terms can be sub-
divided into other purposes, as well. In addition, mul-
tiple types of currents and waveforms may be used
within some of these classifications. For example, NMES
may include biphasic pulsatile current as well as
medium frequency burst-modulated alternating current.
Even IFC has been found to be effective for NMES pur-
poses such as muscular force production [2].
Therefore, I would appreciate seeing the investigation
of electrotherapy, (actually, all EPAs) based on the treat-
ment purpose, at least in addition to if not more so than
a device classification. The authors stated that they in-
cluded questions in their questionnaire, not reported in
the current paper, that were related to indications for
the use of specific electrical current forms, which may
address my concern to some degree. First, the problem to
be treated must be determined, then one can proceed with
the treatment purpose application (e.g., strengthening).
With electrotherapy, the treatment purpose applica-
tions must be based on identifying the neurophysiologic
response that is necessary (e.g., muscle contraction,
for strengthening), and then selecting the appropriate
parameter settings that will create the desired re-
sponse at the appropriate level (e.g., a frequency of
50 pps to create a tetanic contraction, with high
enough current amplitude and current duration, or
charge, for a strong contraction) [3, 4].
Devices of a particular type or classification may have
multiple and varied treatment purpose applications [3].
For example, a TENS device can be used for purposes
other than pain control, such as enhancement of circula-
tion. Similarly, the device classifications used in the
current study have overlapping treatment purpose appli-
cations. For example, both IFC and TENS devices may
be used for pain control. Therefore, frequency of use (as
investigated in the current study) of one type of device
might subtract from that of another device. Conversely,
it could add to the frequency of use based on treatment
purpose.
If clinicians are using one type of device over another
for a treatment purpose for which either type of device
could be used, it would be useful to know this as well as
the reasons for it. On the other hand, it would be useful
to know if the clinician fully understands that a type of
device has multiple treatment purpose applications. If
not, the choice of device might be related to the clinician
not fully understanding the available appropriate op-
tions. The authors of the current study point out that
availability might have meant that the device might not
be available when needed. However, if clinicians were
aware that a particular device has multiple treatment
uses, they might opt to use a different device that could
fulfill the same purpose as the originally desired device if
the latter device was currently being used by another
clinician in their facility. It would also be useful to know
the frequency of use of electrotherapy (or any physical
agent, for that matter) by treatment purpose when the
clinician has identified the treatment purpose and that
there was another option for treatment, and whether or
not more than one of the treatment options were chosen,
as well as the reasons for the clinician’s selections.
Apparent de-emphasis of EPAs in education and practice
The current study has shed some light on the pattern of
use of electrotherapy and other physical agents. This
comes at a point in the evolution of the field of physio-
therapy in which some are suggesting or actually putting
into practice the de-emphasis of EPAs, including electro-
therapy, by physiotherapists. Recently the APTA has
made a strong recommendation to this effect [5]. In
addition, there appears to be a de-emphasis of this area
of the field in entry-level physiotherapy education
curricula in the United States. Some physiotherapy pro-
grams have limited the number of hours for courses on
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EPAs, with some programs allotting only limited hours
for this content within courses on other content.
These sentiments and practices may be associated
with long-held biases regarding overuse of physical
agents without proper application of clinical decision-
making by physiotherapists and use of other, additional
treatment interventions. This might have been an issue
more than 25 years ago, but is not based on sound evi-
dence now [6, 7]. There may also be a misconception that
the evidence for use of electrotherapy is minimal or non-
existent. In addition, electrotherapy and other physical
agents have been pejoratively referred to as passive inter-
ventions. However, other well regarded interventions such
as joint manipulation are passive, and the “passiveness” of
the intervention is not a problem if the intervention is ap-
propriate and applied appropriately. In any case, electro-
therapy and other physical agents, as with most if not all
interventions, are rarely recommended to be used exclu-
sively, unless other interventions would be inappropriate
or less appropriate and provide no additional advantage.
Recommendations for inappropriate limited use or
non-use have the further effect of limiting physiotherap-
ist student and clinician understanding and ability to
appropriately apply electrotherapy and physical agents.
These further feed into rationales for limited and non-use.
This cycle may lead to a predisposition resulting in the re-
moval of EPAs from the physiotherapist’s armamentarium
of interventions.
Conclusions
The current study speaks to the use of EPAs in
Israel by physiotherapists and provides data that can
be built upon to improve continued appropriate use.
EPAs appear to be considered relevant to physiother-
apist practice in Israel. I have provided recommenda-
tions for future study of the use of electrotherapy
and EPAs, including investigations based on treat-
ment purpose. The authors of the current study re-
ported that they have additional data, that they can
report on in the future, which may address these
recommendations.
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